Christine Fisher, MD, MPH

Professor, Radiation Oncology


FacultyPhoto
Medical School
  • MD, Chicago Medical School at Rosalind Franklin University of Medicine & Science (2006)
Graduate School
  • MPH, University of North Carolina at Chapel Hill (2010)
Internship
  • University of Hawaii Program (2007)
Residency
  • University of Texas M D Anderson Cancer Center Program, Radiation Oncology (2011)
Languages
English
Department
Radiation Oncology

Professional Titles

  • Vice Chair, Department of Radiation Oncology
  • Director of Brachytherapy

Recognitions

  • Top Doctor Radiation Oncology, 5280 (2020)
  • Top Doctor Radiation Oncology, 5280 (2019)

Publications

  • A novel technique for the simulation and treatment planning of obese patients. Fisher, CM, Jhingran, A, Fortenberry, B, Eifel, PJ. (2011). Practical Radiation Oncology, July 1(3): 152-155.
  • Knife or needles? A cohort analysis of low and intermediate risk men treated definitively for adenocarcinoma of the prostate. Fisher, CM, Troncoso P, Kuban DA, Munsell M, Yeh S, Lee AK, Swanson DA, Frank SJ. (2011). Submitted, Brachythreapy.
  • Consolidative Radiation Therapy for Stage III Hodgkin Lymphoma in Patients Who Achieve Complete Response After ABVD Chemotherapy. Phan, J, Mazloom, A, Abboud, M, Salehpour, M, Reed, VK, Zreik, T, Shihadeh, F, Fisher, CM, Wogan, C, Dabaja, BS. (2011). American Journal of Clinical Oncology, Accepted, published online..
  • Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients. Peoples GE, Gurney JM, Hueman MT, Woll MM, Ryan GB, Storrer CE, Fisher CM, Shriver CD, Ioannides CG, Ponniah S. (2005). Journal of Clinical Oncology,Oct 20;23(30):7536-45.
  • Fisher CM, Schefter TE. Pelvic radiation therapy for early endometrial cancer: careful selection is key. Oncology (Williston Park). 2013 Oct;27(10):999-1000. PubMed PMID: 24367857
  • Fields EC, DeWitt P, Fisher CM, Rabinovitch R. Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis. Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):747-52. PubMed PMID: 24138917
  • Phase I clinical trial of a HER2/neu peptide (E75) vaccine for the prevention of prostate-specific antigen recurrence in high-risk prostate cancer patients. Hueman MT, Dehqanzada ZA, Novak TE, Gurney JM, Woll MM, Ryan GB, Storrer CE, Fisher CM, McLeod DG, Ioannides CG, Ponniah S, Peoples GE. (2005). Clinical Cancer Research, Oct 15;11(20):7470-9.
  • Direct measurement of peptide-specific CD8+ T cells using HLA-A2:Ig dimer for monitoring the In Vivo immune response to a HER2/neu vaccine in breast and prostate cancer patients. Woll MM, Fisher CM, Ryan GB, Gurney JM, Storrer CE, Ioannides CG, Shriver CD, Moul JW, McLeod DG, Ponniah S, Peoples GE. (2004). Journal of Clinical Immunology, Jul;24(4):449-61.
  • Fisher CM, Diamond JR, Kounalakis N et al. The integration of locoregional with systemic adjuvant therapy for early-stage breast cancer: the shifting sands of decision-making. Breast Cancer Manag. 3(2), 205-212 (2014).
  • Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Jan;15(1):92-120. PubMed PMID: 28040721
  • Stokes WA, Jones BL, Schefter TE, Fisher CM. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis. Brachytherapy. 2018 Jan - Feb;17(1):194-200. PubMed PMID: 29097136
  • Overholser L, Shagisultanova E, Rabinovitch RA, Kounalakis N, Diamond J, Finlayson CA, Fisher CM, Kabos P, Elias AD, Borges VF, Mayordomo J. Breast Cancer Following Radiation for Hodgkin Lymphoma: Clinical Scenarios and Risk-Reducing Strategies. Oncology (Williston Park). 2016 Dec 15;30(12). PubMed PMID: 27987198
  • Quackenbush K, Amini A, Fisher CM, Rabinovitch R. Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer. Cureus. 2017 Jul 2;9(7):e1417. PubMed PMID: 28875090
  • Fields EC, Melvani R, Hajdok G, D'Souza D, Jones B, Stuhr K, Diot Q, Fisher CM, Mukhopadhyay N, Todor D. A Multi-institution, Retrospective Analysis of Cervix Intracavitary Brachytherapy Treatments. Part 1: Is EQD2 Good Enough for Reporting Radiobiological Effects?. Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):219-226. PubMed PMID: 28816149
  • Stokes WA, Amini A, Jackson MW, Plimpton SR, Kounalakis N, Kabos P, Rabinovitch RA, Rusthoven CG, Fisher CM. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States. Clin Breast Cancer. 2017 Jun 29. [Epub ahead of print] PubMed PMID: 28797765
  • Robin TP, Amini A, Schefter TE, Behbakht K, Fisher CM. Disparities in standard of care treatment and associated survival decrement in patients with locally advanced cervical cancer. Gynecol Oncol. 2016 Nov;143(2):319-325. PubMed PMID: 27640961
  • Robin TP, Amini A, Schefter TE, Behbakht K, Fisher CM. Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy. Brachytherapy. 2016 Nov - Dec;15(6):845-850. PubMed PMID: 27720204
  • Amini A, DeWitt PE, Vinogradskiy Y, Rusthoven CG, Altunbas C, Schefter TE, Fisher CM. Should we customize PTV expansions for BMI? Daily cone beam computerized tomography to assess organ motion in postoperative endometrial and cervical cancer patients. Rep Pract Oncol Radiother. 2016 May-Jun;21(3):195-200. PubMed PMID: 27601950
  • Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2016 Jun 8. [Epub ahead of print] PubMed PMID: 27281264
  • Arthur DW, Winter KA, Kuerer HM, Haffty BG, Cuttino LW, Todor DA, Simone NL, Hayes SB, Woodward WA, McCormick B, Cohen RJ, Sahijdak WM, Canaday DJ, Brown DR, Currey AD, Fisher CM, Jagsi R, White J. NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1028-1035. PubMed PMID: 28721885
  • Stokes WA, Robin TP, Jackson MW, Amini A, Schefter TE, Lefkowits CC, Fisher CM. Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis. Am J Clin Oncol. 2017 Jun 26. [Epub ahead of print] PubMed PMID: 28654573
  • Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P. The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?. J Natl Compr Canc Netw. 2017 Apr;15(4):494-503. PubMed PMID: 28404760
  • Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Dizon DS, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Valea FA, Wyse E, Yashar CM, McMillian N, Scavone J. Vulvar Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017 Jan;15(1):92-120. PubMed PMID: 28040721
  • Amini A, Jones BL, Yeh N, Guntupalli SR, Kavanagh BD, Karam SD, Fisher CM. Disparities in disease presentation in the four screenable cancers according to health insurance status. Public Health. 2016 Sep;138:50-6. PubMed PMID: 27091437
  • Jasem J, Amini A, Rabinovitch R, Borges VF, Elias A, Fisher CM, Kabos P. 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile. J Clin Oncol. 2016 Jun 10;34(17):1995-2002. PubMed PMID: 27001563
  • Rusthoven CG, Rabinovitch RA, Jones BL, Koshy M, Amini A, Yeh N, Jackson MW, Fisher CM. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis. Ann Oncol. 2016 May;27(5):818-27. PubMed PMID: 26861597
  • Amini A, Rusthoven CG, Waxweiler TV, Jones BL, Fisher CM, Karam SD, Raben D. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States. J Am Acad Dermatol. 2016 Feb;74(2):309-16. PubMed PMID: 26670715
  • Amini A, Robin TP, Stumpf PK, Rusthoven C, Schefter TE, Shinde A, Chen YJ, Glaser SM, Corr BR, Fisher CM. Rising Rates of Upfront Surgery in Early Locally Advanced Cervical Cancer: What Factors Predict for This Treatment Paradigm?. Int J Gynecol Cancer. 2018 Oct;28(8):1560-1568. PubMed PMID: 30247249
  • Moroney MR, Flink D, Sheeder J, Blake EA, Carrubba AR, Fisher CM, Guntupalli SR. Radiation therapy is not an independent risk factor for decreased sexual function in women with gynecologic cancers. Rep Pract Oncol Radiother. 2018 Sep-Oct;23(5):331-336. PubMed PMID: 30127672
  • Robin TP, Grover S, Reddy Palkonda VA, Fisher CM, Gehl B, Bhattacharya K, Mallick I, Bhattasali O, Viswanathan AN, Sastri Chopra S, Mahantshetty U, Hardenbergh PH. Utilization of a Web-Based Conferencing Platform to Improve Global Radiation Oncology Education and Quality-Proof of Principle Through Implementation in India. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):276-280. PubMed PMID: 30071293
  • Ramzan AA, Fischer S, Buss MK, Urban RR, Patsner B, Duska LR, Fisher CM, Lefkowits C. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part II - Balancing safety & accessibility. Gynecol Oncol. 2018 May;149(2):401-409. PubMed PMID: 29544707
  • Lefkowits C, Buss MK, Ramzan AA, Fischer S, Urban RR, Fisher CM, Duska LR. Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review. Gynecol Oncol. 2018 May;149(2):394-400. PubMed PMID: 29472016
  • Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, George S, Han E, Higgins S, Huh WK, Lurain JR 3rd, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Tillmanns T, Ueda S, Wyse E, Yashar CM, McMillian NR, Scavone JL. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018 Feb;16(2):170-199. PubMed PMID: 29439178
  • Stokes WA, Jones BL, Schefter TE, Fisher CM. Impact of radiotherapy modalities on outcomes in the adjuvant management of uterine carcinosarcoma: A National Cancer Database analysis. Brachytherapy. 2018 Jan - Feb;17(1):194-200. PubMed PMID: 29097136
  • Stokes WA, Amini A, Jackson MW, Plimpton SR, Kounalakis N, Kabos P, Rabinovitch RA, Rusthoven CG, Fisher CM. Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States. Clin Breast Cancer. 2018 Jun;18(3):220-228. PubMed PMID: 28797765
  • Stokes WA, Robin TP, Jackson MW, Amini A, Schefter TE, Lefkowits CC, Fisher CM. Patterns of Adjuvant Therapy Utilization in Uterine Carcinosarcoma Stages I to III: A National Cancer Database Analysis. Am J Clin Oncol. 2018 Oct;41(10):927-932. PubMed PMID: 28654573
  • Amini A, Yeh N, Jones BL, Bedrick E, Vinogradskiy Y, Rusthoven CG, Amini A, Purcell WT, Karam SD, Kavanagh BD, Guntupalli SR, Fisher CM. Perioperative Mortality in Nonelderly Adult Patients With Cancer: A Population-based Study Evaluating Health Care Disparities in the United States According to Insurance Status. Am J Clin Oncol. 2018 May;41(5):476-484. PubMed PMID: 27281264
  • Arthur DW, Winter KA, Kuerer HM, Haffty B, Cuttino L, Todor DA, Anne PR, Anderson P, Woodward WA, McCormick B, Cheston S, Sahijdak WM, Canaday D, Brown DR, Currey A, Fisher CM, Jagsi R, Moughan J, White JR. Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. JAMA Oncol. 2019 Nov 21. [Epub ahead of print] PubMed PMID: 31750868
  • Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Dorigo O, Eifel PJ, Fisher CM, Frederick P, Gaffney DK, Han E, Huh WK, Lurain JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Wyse E, McMillian NR, Scavone J. Gestational Trophoblastic Neoplasia, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2019 Nov 1;17(11):1374-1391. PubMed PMID: 31693991
  • Guy CL, Fields EC, Quinn BA, Fisher CM, Ladbury CJ, Romano KD, Todor D. The vaginal cylinder: Misunderstood, misused, or trivial? An in-depth dosimetric and multiinstitutional outcome investigation. Brachytherapy. 2019 Nov - Dec;18(6):763-770. PubMed PMID: 31558353
  • Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Huh WK, Lurain Iii JR, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Fader AN, Remmenga SW, Reynolds RK, Sisodia R, Tillmanns T, Ueda S, Urban R, Wyse E, McMillian NR, Motter AD. NCCN Guidelines Insights: Cervical Cancer, Version 1.2020. J Natl Compr Canc Netw. 2020 Jun;18(6):660-666. PubMed PMID: 32502976
  • Weiss JA, Nicklawsky A, Kagihara JA, Gao D, Fisher C, Elias A, Borges VF, Kabos P, Davis SL, Leong S, Eckhardt SG, Diamond JR. Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center. Cancer Med. 2020 Dec;9(23):8801-8808. PubMed PMID: 33063469
  • Stumpf PK, Cittelly DM, Robin TP, Carlson JA, Stuhr KA, Contreras-Zarate MJ, Lai S, Ormond DR, Rusthoven CG, Gaspar LE, Rabinovitch R, Kavanagh BD, Liu A, Diamond JR, Kabos P, Fisher CM. Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4. Clin Cancer Res. 2019 Jul 1;25(13):3946-3953. PubMed PMID: 30940654
  • Zakem SJ, Robin TP, Smith DE, Amini A, Stokes WA, Lefkowits C, Fisher CM. Evolving trends in the management of high-intermediate risk endometrial cancer in the United States. Gynecol Oncol. 2019 Mar;152(3):522-527. PubMed PMID: 30876498
  • Robin TP, Grover S, Reddy Palkonda VA, Fisher CM, Gehl B, Bhattacharya K, Mallick I, Bhattasali O, Viswanathan AN, Sastri Chopra S, Mahantshetty U, Hardenbergh PH. Utilization of a Web-Based Conferencing Platform to Improve Global Radiation Oncology Education and Quality-Proof of Principle Through Implementation in India. Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):276-280. PubMed PMID: 30071293
  • Amini A, Robin TP, Rusthoven CG, Schefter TE, Akhavan D, Chen YJ, Glaser SM, Corr BR, Ashing KT, Fisher CM. Disparities Predict for Higher Rates of Cut-through Hysterectomies in Locally Advanced Cervical Cancer. Am J Clin Oncol. 2019 Jan;42(1):21-26. PubMed PMID: 29889138
  • Moroney MR, Davies KD, Wilberger AC, Sheeder J, Post MD, Berning AA, Fisher C, Lefkowits C, Guntupalli SR, Behbakht K, Corr BR. Molecular markers in recurrent stage I, grade 1 endometrioid endometrial cancers. Gynecol Oncol. 2019 Jun;153(3):517-520. PubMed PMID: 30910249
  • Shiao JC, Santoso A, Stuhr K, Bennett SJ, Gao D, Holt DE, Robin T, Fisher CM. Gynecologic interstitial brachytherapy curriculum using a low-cost phantom with ultrasound workshop and a treatment planning workshop is effective. Brachytherapy. 2022 Jan-Feb;21(1):110-119. PubMed PMID: 34876360
  • Ladbury C, Li R, Shiao J, Liu J, Cristea M, Han E, Dellinger T, Lee S, Wang E, Fisher C, Chen YJ, Amini A, Robin T, Glaser S. Characterizing impact of positive lymph node number in endometrial cancer using machine-learning: A better prognostic indicator than FIGO staging?. Gynecol Oncol. 2022 Jan;164(1):39-45. PubMed PMID: 34794840
  • Schreiber AR, Kagihara J, Eguchi M, Kabos P, Fisher CM, Meyer E, Molina E, Kondapalli L, Bradley CJ, Diamond JR. Evaluating anthracycline? ?taxane versus taxane-based chemotherapy in older women with node-negative triple-negative breast cancer: a SEER-Medicare study. Breast Cancer Res Treat. 2022 Jan;191(2):389-399. PubMed PMID: 34705147
  • Abu-Rustum NR, Yashar CM, Bradley K, Campos SM, Chino J, Chon HS, Chu C, Cohn D, Crispens MA, Damast S, Diver E, Fisher CM, Frederick P, Gaffney DK, George S, Giuntoli R, Han E, Howitt B, Huh WK, Lea J, Mariani A, Mutch D, Nekhlyudov L, Podoll M, Remmenga SW, Reynolds RK, Salani R, Sisodia R, Soliman P, Tanner E, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Motter AD. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021. J Natl Compr Canc Netw. 2021 Aug 1;19(8):888-895. PubMed PMID: 34416706
  • Shiao JC, Holt DE, Stuhr K, Schubert L, Robin T, Fisher CM. The Kelowna template for combined intracavitary and interstitial brachytherapy for gynecologic malignancies: Design, application, treatment planning, dosimetric and treatment outcomes. Brachytherapy. 2022 Nov-Dec;21(6):823-832. PubMed PMID: 36192312
  • Park J, Puckett LL, Katsoulakis E, Venkatesulu BP, Kujundzic K, Solanki AA, Movsas B, Simone CB 2nd, Sandler H, Lawton CA, Das P, Wo JY, Buchholz TA, Fisher CM, Harrison LB, Sher DJ, Kapoor R, Chapman CH, Dawes S, Kudner R, Wilson E, Hagan M, Palta J, Kelly MD. Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. Pract Radiat Oncol. 2022 Nov-Dec;12(6):468-474. PubMed PMID: 35690354
  • Abu-Rustum NR, Yashar CM, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Gaillard S, Giuntoli R, Glaser S, Holmes J, Howitt BE, Lea J, Mantia-Smaldone G, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Rodabaugh K, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wyse E, McMillian NR, Aggarwal S, Espinosa S. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024. J Natl Compr Canc Netw. 2023 Dec;21(12):1224-1233. PubMed PMID: 38081139
  • Ladbury C, Harkenrider M, Taunk N, Fisher C, Mayadev J, Venkat P, Yashar C, Gaffney D, Beriwal S, Glaser S. A practical guide to hybrid interstitial/intracavitary brachytherapy for locally-advanced cervical cancer. Brachytherapy. 2023 Sep-Oct;22(5):640-648. PubMed PMID: 37481370
  • Davies KD, Smith LP, Guimaraes-Young A, Corr BR, Fisher CM, Guntupalli SR, Berning AA, Post MD, Pino D, Aisner DL, Wolsky RJ. Prospective Clinical Prognostication of Endometrial Carcinomas Based on Next-Generation Sequencing and Immunohistochemistry-Real-World Implementation and Results at a Tertiary Care Center. Int J Gynecol Pathol. 2023 Oct 4. [Epub ahead of print] PubMed PMID: 37922951
  • Abu-Rustum N, Yashar C, Arend R, Barber E, Bradley K, Brooks R, Campos SM, Chino J, Chon HS, Chu C, Crispens MA, Damast S, Fisher CM, Frederick P, Gaffney DK, Giuntoli R, Han E, Holmes J, Howitt BE, Lea J, Mariani A, Mutch D, Nagel C, Nekhlyudov L, Podoll M, Salani R, Schorge J, Siedel J, Sisodia R, Soliman P, Ueda S, Urban R, Wethington SL, Wyse E, Zanotti K, McMillian NR, Aggarwal S. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2023 Feb;21(2):181-209. PubMed PMID: 36791750
  • Travers SS, Fisher CM, Kabos P, Cittelly DM, Ormond DR. Breast cancer brain metastases localization and risk of hydrocephalus: a single institution experience. J Neurooncol. 2023 May;163(1):115-121. PubMed PMID: 37131107

Practice Locations

UCHealth Radiation Oncology - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0100

University of Colorado Cancer Center - Anschutz Medical Campus
1665 Aurora Ct
Aurora, CO 80045
720-848-0300

Hospital Affiliation
  • University of Colorado Hospital

Center Affiliations

Specialty Information

Specialties
  • Radiation Oncology, Board Certification (2011)
Conditions & Treatments
  • Cancers
  • Cancers - Breast Cancer
  • Cancers - Cervical Cancer
  • Cancers - Gynecologic Cancer
  • Cancers - Uterine Cancer
  • Cancers - Radiation Therapy
  • Cancers - Ovarian Cancer